IRIDEX Corporation(IRIX) stock price and fundamentals

Medical - Devices · Mountain View, CA

$0.70+0.01 (+1.48%)

Delayed quote: Oct 6, 2026, 9:59 AM EDT

About IRIDEX Corporation

IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.

Mountain View, CA

93 employees

www.iridex.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Patrick Mercer

View full financials

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR	Compare
1IRIX	$12.12M	$0.70	+1.48%	-42.35%	-38.13%	-26.14%	N/A
2LTRN	$11.99M	$0.94	-0.01%	-76.97%	-37.05%	N/A	vs IRIX
3ADIL	$11.74M	$4.47	+2.76%	-56.33%	-71.86%	N/A	vs IRIX
4CTSO	$12.66M	$4.03	+1.64%	-79.67%	-52.26%	-28.72%	vs IRIX
5DARE	$12.68M	$0.85	+0.40%	-61.15%	-46.35%	-39.10%	vs IRIX
6LSTA	$11.47M	$1.26	+0.00%	-49.83%	-40.75%	-32.84%	vs IRIX

Period	Low	Avg	High	# Analysts
Quarter ending Oct 2026	$-0.04	$-0.04	$-0.04	1
Quarter ending Jan 2027	$0.02	$0.02	$0.02	1

Period	Low	Avg	High	# Analysts
FY 2027	$-0.12	$-0.12	$-0.12	1
FY 2028	$0.02	$0.02	$0.02	1

Period	Low	Avg	High	# Analysts
Quarter ending Oct 2026	$12.64M	$12.64M	$12.64M	1
Quarter ending Jan 2027	$15.51M	$15.51M	$15.51M	1

Period	Low	Avg	High	# Analysts
FY 2027	$52.52M	$52.52M	$52.52M	1
FY 2028

IRIDEX Corporation(IRIX) stock price and fundamentals

Valuation

Yields

IRIX Price Chart

Business at a glance

IRIX Key Metrics

Total Return CAGR

IRIX Fundamental Charts

Revenue CAGR

IRIX Selected Revenue Disclosures

Product / business disclosures (FY 2025)

Geographic disclosures (FY 2025)

IRIX Earnings Preview

Similar-Size Sector Stocks

IRIX Competitors' Key Metrics

IRIX Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

IRIX Analyst Ratings

IRIX Analyst Estimates

Earnings Per Share (EPS) Estimates

Revenue Estimates